Trial
NCT04629196
Induction Optimization With Stelara for Crohn's Disease
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
—
Condition
Crohn Disease
Intervention
Ustekinumab
Why stopped
Other effective drugs have been introduced to market since the beginning of the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-05